Adaptive Biotechnologies to Report Third Quarter Financial Results on November 10, 2020
October 13 2020 - 4:05PM
Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial
stage biotechnology company that aims to translate the genetics of
the adaptive immune system into clinical products to diagnose and
treat disease, today announced it will report financial results for
the third quarter ended September 30, 2020 after market close on
Tuesday, November 10, 2020. Company management will webcast a
corresponding conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the “Investors” section of the company website at:
www.adaptivebiotech.com. The webcast will be archived and available
for replay within 24 hours after the event.
About Adaptive Biotechnologies
Adaptive Biotechnologies is a
commercial-stage biotechnology company focused on harnessing the
inherent biology of the adaptive immune system to transform the
diagnosis and treatment of disease. We believe the adaptive immune
system is nature’s most finely tuned diagnostic and therapeutic for
most diseases, but the inability to decode it has prevented the
medical community from fully leveraging its capabilities. Our
proprietary immune medicine platform reveals and translates the
massive genetics of the adaptive immune system with scale,
precision and speed to develop products in life sciences research,
clinical diagnostics and drug discovery. We have two commercial
products and a robust clinical pipeline to diagnose, monitor and
enable the treatment of diseases such as cancer, autoimmune
conditions and infectious diseases. Our goal is to develop and
commercialize immune-driven clinical products tailored to each
individual patient.
ADAPTIVE MEDIABeth
Keshishian917-912-7195media@adaptivebiotech.com
ADAPTIVE INVESTORSKarina Calzadilla, Vice
President, Investor Relations201-396-1687Carrie
Mendivil, Gilmartin Groupinvestors@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Apr 2023 to Apr 2024